Table 5 Bacteriology and clinical outcome in nine cases with Alcaligenes faecalis infection
From: Extensively drug-resistant Alcaligenes faecalis infection
| Â | Case 1 | Case2 | Case 3 | Case 4 | Case 5 | Case 6 | Case7 | Case8 | Case9 |
|---|---|---|---|---|---|---|---|---|---|
year | 2016 | 2018 | 2017 | 2019 | 2015 | 2016 | 2016 | 2016 | 2019 |
prior intravenous antibiotic use within 90 days | NIL | AMC | No | No | CAZ CIP MEM | No | No | CFZ | No |
Antibiotics therapy | MXF AMC | CAZ | OFX | SXT | CAZ | CFZ | CTB | CFZ | TEC CRO |
outcome | cure | cure | cure | cure | cure | cure | cure | cure | cure |
Results of antibiotics sensitivity test of Alcaligenes faecalis | |||||||||
 GEN | R | S | S | S | S | R | NIL | NIL | S |
 AMK | S | S | S | S | S | S | NIL | NIL | S |
 CAZ | R | S | S | S | S | R | NIL | NIL | S |
 FEP | R | S | S | S | S | R | NIL | NIL | S |
 SAM | R | S | S | S | S | R | NIL | NIL | S |
 TZP | R | S | S | S | S | R | NIL | NIL | S |
 CIP | R | S | S | R | R | S | NIL | NIL | S |
 IPM | S | S | S | S | S | S | NIL | NIL | S |
 MEM | S | S | S | S | S | S | NIL | NIL | S |
 TGC | NA | NA | NA | NA | NA | NA | NA | NA | NA |
Mixed infection pathogens | |||||||||
 Enterococcus |  |  |  |  |  |  |  |  | V |
 Proteus vulgaris |  |  |  |  |  |  |  | V | V |
 Enterobacter cloacae |  | V |  |  | V |  |  |  |  |
 Pseudomonas aeruginosa | V |  | V |  |  |  |  | V | V |
 Acinetobacter baumannii |  | V |  |  |  |  |  |  |  |
 Escherichia coli |  |  |  |  |  |  | V |  |  |
 Serratia marcescens |  |  |  | V |  |  |  |  |  |
 Providencia stuartii | V |  |  |  |  |  |  |  |  |
 MSSA |  |  |  | V |  |  |  |  |  |
 Streptococcus group D |  |  |  |  |  |  | V |  |  |
 Aeromonas hydrophila |  |  |  |  |  | V |  |  |  |